GO:0015918 sterol transport: Mechanism, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0015918 sterol transport describes the directed movement of sterols into, out of, or within a cell, or between cells, via transporters or pores.
Sterol transport occurs through both vesicular and non-vesicular mechanisms, with non-vesicular pathways enabling rapid exchange between organelles.
Key protein families include ABC transporters, oxysterol-binding protein homologues (OSH), and aster proteins that mediate non-vesicular sterol transfer.
Defects in sterol transport are linked to cardiovascular disease, neurodegeneration, and cancer through altered cholesterol homeostasis.
CRISPR knockout, point mutation, knock-in, and overexpression models are essential for dissecting sterol transport gene function.
Studying sterol transport requires integrated methods such as imaging, lipidomics, and CRISPR library screening to capture dynamic sterol fluxes.

Description

Sterol transport (GO:0015918) is a fundamental biological process that governs the directed movement of sterols, such as cholesterol in mammals and ergosterol in yeast, into, out of, or within cells, or between cells, by means of transporters or pores. Sterols are steroids with one or more hydroxyl groups and a hydrocarbon side-chain, and their proper distribution is critical for membrane integrity, signaling, and lipid metabolism. This process is essential for maintaining cellular cholesterol homeostasis and for supplying sterols to organelles where they perform specialized functions. Researchers study sterol transport to understand how cells coordinate lipid uptake, efflux, and intracellular trafficking, and how disruptions contribute to disease. The field has advanced through identification of protein families such as ABC transporters, oxysterol-binding protein homologues (OSH), and aster proteins, which mediate distinct transport steps. This article provides a comprehensive overview of the molecular mechanisms, key genes, regulatory features, disease associations, and experimental approaches for investigating sterol transport.

sterol transport At A Glance

GO ID GO:0015918
GO term sterol transport
Ontology biological_process
Synonym none
Major function Directed movement of sterols into, out of, or within a cell, or between cells, via transporters or pores
Key protein families ABC transporters, OSH proteins, aster proteins, NPC1, NPC2
Subcellular locations Plasma membrane, endoplasmic reticulum, Golgi, endosomes, lysosomes, mitochondria
Associated diseases Niemann-Pick disease type C, atherosclerosis, neurodegeneration, cancer

What Is GO:0015918?

Sterol transport is the directed movement of sterols into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. Sterols are steroids with one or more hydroxyl groups and a hydrocarbon side-chain in the molecule. This process encompasses both vesicular and non-vesicular mechanisms that ensure proper sterol distribution across cellular membranes.

Why Is sterol transport Important in Cell Biology?

Sterol transport is vital for cellular cholesterol homeostasis, membrane organization, and lipid signaling, and its dysfunction is implicated in a wide range of human diseases including cardiovascular disorders, neurodegenerative conditions, and cancer. Understanding the molecular players and regulatory mechanisms of sterol transport provides opportunities for therapeutic intervention and for interpreting genetic variants associated with lipid disorders.
Maintains cholesterol distribution between organelles and plasma membrane.
Regulates membrane fluidity, permeability, and lipid raft formation.
Controls dietary cholesterol uptake and reverse cholesterol transport.
Dysregulation leads to atherosclerosis and cardiovascular disease.
Mutations in sterol transport genes cause Niemann-Pick disease type C.
Implicated in neurodegeneration through altered brain cholesterol metabolism.
Supports cancer cell proliferation by sustaining sterol supply.
Provides targets for lipid-lowering and anti-cancer therapies.
Essential for yeast ergosterol trafficking and cell viability.
Enables rapid non-vesicular sterol exchange between organelles.

What Happens During sterol transport?

Sterol uptake and delivery to the plasma membrane
In simple terms: Cells take in sterols from outside and move them to the outer membrane.
Dietary cholesterol uptake in the intestine involves aster-dependent non-vesicular transport, which facilitates the transfer of sterols from the plasma membrane to the endoplasmic reticulum. In yeast, sterol uptake is mediated by ABC transporters and other permeases that translocate sterols across the plasma membrane. This step is critical for maintaining cellular sterol pools and for sensing external lipid availability.
Intracellular distribution via non-vesicular pathways
In simple terms: Sterols are shuttled between organelles without using membrane vesicles.
Non-vesicular sterol transport occurs at membrane contact sites where proteins such as OSH homologues and aster proteins transfer sterols between the endoplasmic reticulum and plasma membrane or endosomes. This process is rapid and energy-independent, allowing cells to respond quickly to sterol fluctuations. The speed limits of non-vesicular transport are determined by protein-mediated sterol exchange and membrane lipid composition.
Vesicular sterol transport
In simple terms: Sterols can also be carried inside membrane-bound vesicles.
Vesicular transport moves sterols between organelles via coated vesicles, as part of the secretory and endocytic pathways. This route contributes to the delivery of newly synthesized sterols from the endoplasmic reticulum to the plasma membrane and to the redistribution of endocytosed cholesterol. Vesicular and non-vesicular pathways cooperate to maintain sterol homeostasis.
Sterol efflux and reverse transport
In simple terms: Cells export excess sterols to prevent toxicity.
ABC transporters such as ABCA1 and ABCG1 mediate the efflux of cholesterol from cells to extracellular acceptors like HDL, a key step in reverse cholesterol transport. This process is essential for preventing cholesterol accumulation in macrophages and for protecting against atherosclerosis. Efflux is regulated by nuclear receptors and lipid-sensing pathways.

Key Genes Involved in GO:0015918 sterol transport

The following genes and proteins are central to sterol transport, as identified in yeast and mammalian systems.
GeneMajor RoleResearch Relevance
ABCA1Cholesterol efflux to ApoA-ITarget for atherosclerosis and HDL therapy
ABCG1Cholesterol efflux to HDLLinked to macrophage cholesterol homeostasis
NPC1Endosomal cholesterol exportMutations cause Niemann-Pick type C
NPC2Lysosomal cholesterol transferDefects lead to NPC disease
OSH1-7Non-vesicular sterol transfer in yeastModel for oxysterol-binding protein function
ASTERNon-vesicular cholesterol uptakeMediates dietary cholesterol absorption
CERTCeramide and sterol transferLinks sphingolipid and sterol metabolism
STARD3Endosomal sterol transportImplicated in cholesterol trafficking
STARD4Non-vesicular sterol transportRegulates ER cholesterol levels
OSBPSterol and phosphatidylinositol 4-phosphate exchangeControls Golgi sterol homeostasis
SCAPSterol sensing and SREBP processingRegulates cholesterol synthesis
INSIGSterol sensing in ERModulates SREBP and HMG-CoA reductase
ABCA7Phospholipid and sterol transportAssociated with Alzheimer's disease
ABCG5/G8Sterol excretion in liver and intestineMutations cause sitosterolemia
LAMP1Lysosomal marker in sterol transport studiesUsed to track cholesterol trafficking
PCSK9LDL receptor degradationTherapeutic target for hypercholesterolemia
HMGCRCholesterol synthesisFeedback regulated by sterol transport

How Is sterol transport Regulated?

Sterol transport is regulated at multiple levels, including transcriptional control by sterol regulatory element-binding proteins (SREBPs) and nuclear receptors such as LXR, which sense cellular sterol levels and modulate the expression of transport proteins like ABCA1 and ABCG1. Post-translational mechanisms, including phosphorylation and ubiquitination, control the activity and localization of sterol transport proteins. In yeast, the OSH proteins are regulated by phosphatidylinositol 4-phosphate and other lipids, ensuring proper sterol distribution. Additionally, membrane contact sites serve as regulatory hubs where lipid transfer proteins are dynamically assembled and disassembled in response to cellular cues.

sterol transport and Human Disease

GeneDisease / BiologyPotential Experimental Model
NPC1Niemann-Pick disease type CKnockout HeLa or neuronal cells; point mutation knock-in
ABCA1Atherosclerosis, Tangier diseaseKnockout macrophages; overexpression in hepatocytes
ABCG1Cardiovascular diseaseKnockout mouse models; CRISPR KO in cell lines
ABCA7Alzheimer's diseaseKnockout iPSC-derived neurons; knock-in of risk variants
OSBPCancer, viral replicationKnockout yeast or mammalian cells; point mutations
Niemann-Pick disease type C
Mutations in NPC1 or NPC2 cause Niemann-Pick disease type C, a lysosomal storage disorder characterized by accumulation of unesterified cholesterol and other lipids in late endosomes and lysosomes. Defective sterol transport leads to neurodegeneration, hepatosplenomegaly, and premature death. Research on NPC proteins has illuminated fundamental mechanisms of endosomal sterol export.
Atherosclerosis and cardiovascular disease
Impaired cholesterol efflux from macrophages, often due to ABCA1 or ABCG1 dysfunction, promotes foam cell formation and atherosclerosis. Reverse cholesterol transport mediated by these transporters is a major protective pathway against cardiovascular disease. Therapeutic strategies aim to enhance sterol efflux and improve HDL function.
Neurodegeneration
Altered sterol transport in the brain is linked to Alzheimer's disease and other neurodegenerative disorders. ABCA7 and APOE, which participate in cholesterol trafficking, are risk factors for late-onset Alzheimer's disease. Disrupted neuronal cholesterol homeostasis contributes to synaptic dysfunction and cognitive decline.
Cancer
Cancer cells often reprogram sterol transport to support rapid proliferation and survival. Overexpression of ABC transporters can confer multidrug resistance, while altered cholesterol uptake fuels membrane biogenesis. Targeting sterol transport pathways is an emerging therapeutic strategy in oncology.

From sterol transport-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of NPC1 impair endosomal sterol export?CRISPR knockout of NPC1 in HeLa or neuronal cells
How do point mutations in ABCA1 affect cholesterol efflux?Point mutation knock-in via CRISPR in macrophages
Can overexpression of ASTER enhance dietary cholesterol uptake?Overexpression of ASTER in intestinal cell lines
What is the role of OSH proteins in non-vesicular sterol transport?Knockout of OSH genes in yeast; tagged knock-in for localization
Does ABCG1 deficiency alter HDL-mediated efflux?Knockout mouse models and CRISPR KO cell lines
How do disease-associated variants in ABCA7 affect sterol transport?Knock-in of variants in iPSC-derived neurons

How to Study the sterol transport Process

MethodWhat It MeasuresTypical Application
Filipin stainingFree cholesterol distributionVisualizing cholesterol accumulation in NPC disease models
BODIPY-cholesterol uptakeSterol uptake and traffickingLive-cell imaging of non-vesicular transport
Lipidomics (LC-MS)Sterol species quantificationProfiling cholesterol and oxysterols in knockout cells
CRISPR knockout screenGene essentiality for sterol transportIdentifying novel regulators of cholesterol efflux
Proximity ligation assayProtein-protein interactions at contact sitesDetecting OSH-ER interactions
Fluorescence resonance energy transfer (FRET)Sterol transfer between membranesMeasuring non-vesicular transport rates
Subcellular fractionationSterol content in organellesValidating transport defects in disease models
RNA-seqTranscriptional changes in sterol transport genesAssessing SREBP pathway activation
Imaging-based sterol trafficking assays
Fluorescent sterol analogs such as filipin or BODIPY-cholesterol combined with live-cell imaging allow real-time visualization of sterol transport between organelles. These methods reveal the dynamics of non-vesicular transfer at membrane contact sites.
Lipidomics and mass spectrometry
Mass spectrometry-based lipidomics quantifies sterol species and their distribution across subcellular fractions, providing a snapshot of transport efficiency. This approach is essential for validating genetic models of sterol transport.
CRISPR library screening
Genome-wide CRISPR knockout or activation screens can identify novel regulators of sterol transport by selecting for cells with altered cholesterol uptake or efflux. Hits are validated using targeted knockout or overexpression.
Biochemical transport assays
In vitro assays using isolated organelles or reconstituted liposomes measure sterol transfer rates mediated by purified proteins such as OSH or aster. These assays define the kinetic parameters and specificity of transport proteins.

How CRISPR Can Be Used to Study GO:0015918 sterol transport

Knockout

CRISPR knockout of sterol transport genes such as NPC1, ABCA1, or OSH homologues enables loss-of-function studies to determine their role in cholesterol trafficking and disease phenotypes. Knockout cell lines are valuable for drug screening and for validating transport pathways.

Point Mutation

Introducing disease-associated point mutations (e.g., in NPC1 or ABCA1) via CRISPR base editing or homology-directed repair allows precise modeling of functional defects in sterol transport. These models help distinguish pathogenic variants from benign polymorphisms.

Knock-in

Knock-in of tagged versions of sterol transport proteins (e.g., GFP-OSBP or HA-ASTER) facilitates localization and interaction studies in live cells. Knock-in of reporter cassettes can also monitor transport activity in real time.

Overexpression

CRISPR activation or cDNA overexpression of genes like ASTER or ABCA1 boosts sterol transport capacity, enabling gain-of-function experiments to test sufficiency in uptake or efflux. Overexpression models are useful for identifying rate-limiting steps.

How EDITGENE Supports sterol transport Research

Researchers studying sterol transport-related genes often need to determine whether a candidate gene is causally involved in sterol movement, disease progression, or drug response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for sterol transport research.

Frequently Asked Questions About sterol transport

Sterol transport (GO:0015918) is the directed movement of sterols into, out of, or within a cell, or between cells, by means of transporters or pores.
Key genes include ABCA1, ABCG1, NPC1, NPC2, OSH homologues, ASTER, and OSBP, among others.
Non-vesicular transport uses lipid transfer proteins at membrane contact sites to shuttle sterols between organelles without vesicles.
Niemann-Pick disease type C, atherosclerosis, Alzheimer's disease, and cancer are associated with sterol transport defects.
NPC1 mediates the export of cholesterol from late endosomes and lysosomes; mutations cause Niemann-Pick disease type C.
CRISPR knockout, point mutation, knock-in, and overexpression enable functional dissection of sterol transport genes in cell models.
Common methods include filipin staining, BODIPY-cholesterol imaging, lipidomics, and biochemical transport assays.
Yes, yeast sterol transport involves OSH proteins and ABC transporters, serving as a model for mammalian pathways.
Vesicular transport uses membrane-bound carriers, while non-vesicular transport relies on protein-mediated transfer at contact sites.
It is regulated by SREBP and LXR transcription factors, post-translational modifications, and lipid signals such as phosphatidylinositol 4-phosphate.

Conclusion

Sterol transport (GO:0015918) is a central biological process that ensures proper distribution of cholesterol and other sterols within and between cells. Its molecular mechanisms involve a diverse set of transporters and lipid transfer proteins, and its dysfunction underlies major human diseases. Continued research using CRISPR-based models and advanced imaging will further illuminate how sterol transport is regulated and how it can be targeted therapeutically.

References

  1. 1. Wang Y et al.. 2023. [Sterol transport proteins in yeast: a review].. Sheng Wu Gong Cheng Xue Bao 39(8):3204-3218 PMID: 37622356
  2. 2. Plummer AM et al.. 2021. The ABCs of Sterol Transport.. Annu Rev Physiol 83:153-181 PMID: 33141631
  3. 3. Prinz WA. 2007. Non-vesicular sterol transport in cells.. Prog Lipid Res 46(6):297-314 PMID: 17709145
  4. 4. Dittman JS et al.. 2017. Speed Limits for Nonvesicular Intracellular Sterol Transport.. Trends Biochem Sci 42(2):90-97 PMID: 27956059
  5. 5. Maxfield FR et al.. 2006. Intracellular sterol transport and distribution.. Curr Opin Cell Biol 18(4):379-85 PMID: 16806879
  6. 6. Schulz TA et al.. 2007. Sterol transport in yeast and the oxysterol binding protein homologue (OSH) family.. Biochim Biophys Acta 1771(6):769-80 PMID: 17434796
  7. 7. Ferrari A et al.. 2023. Aster-dependent nonvesicular transport facilitates dietary cholesterol uptake.. Science 382(6671):eadf0966 PMID: 37943936
  8. 8. Mesmin B et al.. 2013. Insights into the mechanisms of sterol transport between organelles.. Cell Mol Life Sci 70(18):3405-21 PMID: 23283302
Contact Us
*
*
*
*
How did you hear about us: